US Stock MarketDetailed Quotes
TERN Terns Pharmaceuticals
- 6.080
- -0.260-4.10%
Trading Nov 29 10:32 ET
516.43MMarket Cap-5152P/E (TTM)
6.385High6.070Low205.01KVolume6.360Open6.340Pre Close1.26MTurnover0.35%Turnover RatioLossP/E (Static)84.94MShares11.40052wk High1.42P/B353.45MFloat Cap4.32052wk Low--Dividend TTM58.13MShs Float28.360Historical High--Div YieldTTM4.97%Amplitude1.450Historical Low6.168Avg Price1Lot Size
About Terns Pharmaceuticals Company
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Company Profile
SymbolTERN
Company NameTerns Pharmaceuticals
Listing DateFeb 5, 2021
Issue Price17.00
Founded2017
CEOMs. Amy Burroughs
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1065 East Hillsdale Boulevard,Suite 100
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-525-5535
Websitehttp://www.ternspharma.com
Company Executives
- Name
- Position
- Salary
- Amy Burroughs
- Chief Executive Officer and Director
- --
- Melita Sun Jung
- Chief Business Officer
- --
- Elona Kogan
- Chief Legal Officer
- --
- Dr. Mark J. Vignola, PhD
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 3.14M
- Dr. Emil T. Kuriakose, M.D.
- President and Head, Research and Development
- --
- David Fellows
- Chairman of the Board
- 340.15K
- Dr. Erin Quirk, M.D.
- President and Head of Research and Development
- 4.67M
- Heather D. Turner
- Director
- --
- Dr. Radhika Tripuraneni, M.D.,M.P.H.
- Director
- 303.06K
- Jill M. Quigley, Esq.
- Independent Director
- 306.14K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 298.99K
- Jeffrey B. Kindler, Esq.
- Independent Director
- 304.99K
- Dr. Hongbo Lu, PhD
- Independent Director
- 299.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data